Stockreport

Lisata (LSTA) Stock Up More Than 35% in 3 Months: Here's Why [Yahoo! Finance]

Lisata Therapeutics, Inc.  (LSTA) 
PDF This clinical-stage biopharmaceutical company is developing its lead product candidate, LSTA1, targeting a range of solid tumors. LSTA1 is an investigational drug tha [Read more]